Hot Pursuit     15-Feb-24
Biocon Ltd rises for third straight session
Biocon Ltd is quoting at Rs 274.6, up 1.07% on the day as on 12:49 IST on the NSE. The stock is up 13.07% in last one year as compared to a 21.22% jump in NIFTY and a 51.05% jump in the Nifty Pharma index.

Biocon Ltd is up for a third straight session today. The stock is quoting at Rs 274.6, up 1.07% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.11% on the day, quoting at 21863.25. The Sensex is at 71855.64, up 0.05%. Biocon Ltd has slipped around 4.52% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has slipped around 7.25% in last one month and is currently quoting at 18584.35, down 0.04% on the day. The volume in the stock stood at 28.2 lakh shares today, compared to the daily average of 72.65 lakh shares in last one month.

The benchmark February futures contract for the stock is quoting at Rs 275.35, up 0.86% on the day. Biocon Ltd is up 13.07% in last one year as compared to a 21.22% jump in NIFTY and a 51.05% jump in the Nifty Pharma index.

The PE of the stock is 0 based on TTM earnings ending December 23.

Previous News
  Biocon consolidated net profit declines 56.74% in the March 2024 quarter
 ( Results - Announcements 16-May-24   18:25 )
  Sensex spurts 901 pts; Nifty above 22,400; European mkt opens higher
 ( Market Commentary - Mid-Session 28-Mar-24   13:36 )
  Biocon Biologics completes integration of Viatris' biosimilars business in 31 European countries
 ( Corporate News - 30-Nov-23   16:49 )
  Biocon reports consolidated net loss of Rs 41.80 crore in the December 2022 quarter
 ( Results - Announcements 15-Feb-23   07:55 )
  Biocon Biologics receives UDFDA approval for Yesafili™
 ( Corporate News - 21-May-24   09:13 )
  Biocon Ltd spurts 2.7%, up for third straight session
 ( Hot Pursuit - 05-Apr-23   13:05 )
  Biocon to declare Quarterly Result
 ( Corporate News - 24-Apr-23   11:48 )
  Biocon Biologics' new mAbs drug substance facility undergoes HPRA's GMP inspection
 ( Corporate News - 04-May-22   08:33 )
  Biocon acquires facility of Eywa Pharma in US for $7.7 mln
 ( Hot Pursuit - 02-Sep-23   14:59 )
  Biocon inks pact with Juno Pharma for commercialization of Liraglutide
 ( Hot Pursuit - 09-Oct-23   10:11 )
  Biocon consolidated net profit declines 66.09% in the September 2022 quarter
 ( Results - Announcements 15-Nov-22   08:42 )
Other Stories
  Marico's domestic biz sees modest volume growth in Q1
  06-Jul-24   12:25
  Titan revenue rises 9% YoY, adds 61 stores in Q1
  06-Jul-24   11:09
  Dabur India expects mid to high digit revenue growth in Q1
  06-Jul-24   10:40
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
Back Top